$BA Balance Sheet | Understand Stock

$BA

$171.50 -$16.82 (8.93%) Live

$BA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Financial Position

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Cash and cash equivalents
Short-term and other investments
Accounts receivable, net
Unbilled receivables, net
Current portion of financing receivables, net
Inventories
Other current assets, net
Assets held for sale
Total current assets
Financing receivables and operating lease equipment, net
Property, plant and equipment, net of accumulated depreciation of $24,318 and $23,613
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Goodwill
Acquired intangible assets, net
Deferred income taxes
Investments
Other assets, net of accumulated amortization of $1,138 and $1,014
Other assets, accumulated amortization
Total assets
Liabilities and equity
Accounts payable
Accrued liabilities
Advances and progress billings
Short-term debt and current portion of long-term debt
Liabilities held for sale
Total current liabilities
Deferred income taxes
Accrued retiree health care
Accrued pension plan liability, net
Other long-term liabilities
Long-term debt
Total liabilities
Shareholders’ equity:
Mandatory convertible preferred stock, 6.00% Series A, par value $1.00 – 20,000,000 shares authorized; 5,750,000 shares issued; aggregate liquidation preference $5,750
Common stock, par value $5.00 – 1,200,000,000 shares authorized; 1,012,261,159 shares issued
Common Stock, Par Value
Common Stock, Shares Authorized
Common Stock, Shares, Issued
Additional paid-in capital
Treasury stock, at cost - 416,639,182 and 423,343,707 shares
Treasury stock, at cost – 222,468,625 and 227,562,887 shares
Retained earnings
Accumulated other comprehensive loss
Total shareholders' equity
Noncontrolling interests
Total equity

Total liabilities and equity

Comments